« Back to Record
Citation APA

Declercq, J., Van Damme, K. K., De Leeuw, E., Maes, B., Bosteels, C., Tavernier, S. J., De Buyser, S., Colman, R., Hites, M., Verschelden, G., Fivez, T., Moerman, F., Demedts, I. K., Dauby, N., De Schryver, N., Govaerts, E., Vandecasteele, S. J., Van Laethem, J., Anguille, S., van der Hilst, J., Misset, B., Slabbynck, H., Wittebole, X., Liénart, F., Legrand, C., Buyse, M., Stevens, A. D., Bauters, F., Seys, L. L., Aegerter, H., Smole, U., Bosteels, V., Hoste, L., Naesens, L., Haerynck, F., Vandekerckhove, L., Depuydt, P., Van Braeckel, E., Rottey, S., Peene, I., Van Der Straeten, C., Hulstaert, F., & Lambrecht, B. N. (2021). Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. The Lancet Respiratory Medicine, 9(12), 1427-1438. doi:10.1016/S2213-2600(21)00377-5


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/345120

Declercq, J., Van Damme, K. K., De Leeuw, E., Maes, B., Bosteels, C., Tavernier, S. J., De Buyser, S., Colman, R., Hites, M., Verschelden, G., Fivez, T., Moerman, F., Demedts, I. K., Dauby, N., De Schryver, N., Govaerts, E., Vandecasteele, S. J., Van Laethem, J., Anguille, S., van der Hilst, J., Misset, B., Slabbynck, H., Wittebole, X., Liénart, F., Legrand, C., Buyse, M., Stevens, A. D., Bauters, F., Seys, L. L., Aegerter, H., Smole, U., Bosteels, V., Hoste, L., Naesens, L., Haerynck, F., Vandekerckhove, L., Depuydt, P., Van Braeckel, E., Rottey, S., Peene, I., Van Der Straeten, C., Hulstaert, F., & Lambrecht, B. N. (2021). Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. The Lancet Respiratory Medicine, 9(12), 1427-1438. doi:10.1016/S2213-2600(21)00377-5